Traws Pharma (TRAW) Equity Ratio (2016 - 2025)
Traws Pharma (TRAW) has disclosed Equity Ratio for 14 consecutive years, with 0.37 as the latest value for Q3 2025.
- On a quarterly basis, Equity Ratio rose 260.55% to 0.37 in Q3 2025 year-over-year; TTM through Sep 2025 was 0.37, a 260.55% increase, with the full-year FY2024 number at 1.27, down 369.32% from a year prior.
- Equity Ratio was 0.37 for Q3 2025 at Traws Pharma, down from 0.53 in the prior quarter.
- In the past five years, Equity Ratio ranged from a high of 0.83 in Q4 2021 to a low of 5.65 in Q2 2024.
- A 5-year average of 0.16 and a median of 0.62 in 2023 define the central range for Equity Ratio.
- Peak YoY movement for Equity Ratio: tumbled 1010.43% in 2024, then soared 260.55% in 2025.
- Traws Pharma's Equity Ratio stood at 0.83 in 2021, then decreased by 13.51% to 0.72 in 2022, then crashed by 34.57% to 0.47 in 2023, then tumbled by 369.32% to 1.27 in 2024, then surged by 128.83% to 0.37 in 2025.
- Per Business Quant, the three most recent readings for TRAW's Equity Ratio are 0.37 (Q3 2025), 0.53 (Q2 2025), and 0.31 (Q1 2025).